Identification of a Multistate Continuous-Time Nonhomogeneous Markov Chain Model for Patients with Decreased Renal Function

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Medical decision making

• Publication date

  2013-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/0272989X12466731PMID 23275452
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Frailties in multi-state models: Are they identifiable? Do we need them?

  2015cited by this paper
• The Analysis of Survival Data

  2012cited by this paper
• Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts.

  2011cited by this paper
• Time-dependent impact of diabetes on the mortality of patients on renal replacement therapy: a population-based study in Germany (2002-2009).

  2011cited by this paper
• The use of eGFR and ACR to predict decline in renal function in people with diabetes.

  2011cited by this paper
• Incidence of renal replacement therapy (RRT) in the diabetic compared with the non-diabetic population in a German region, 2002-08.

  2011cited by this paper
• The effect of diabetes on incidence and mortality in end-stage renal disease in Germany.

  2011cited by this paper
• Joint Analysis of Health Histories, Physiological State, and Survival

  2011cited by this paper
• Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study.

  2010cited by this paper
• A Maximum Likelihood Estimator of a Markov Model for Disease Activity in Crohn’s Disease and Ulcerative Colitis for Annually Aggregated Partial Observations

  2010cited by this paper
• Risk factors for end-stage renal disease: 25-year follow-up.

  2009cited by this paper
• Estimating dementia-free life expectancy for Parkinson's patients using Bayesian inference and microsimulation

  2009cited by this paper
• UK Renal Registry 11th Annual Report (December 2008): Chapter 14 UK Renal Registry and international comparisons

  2009cited by this paper
• A new equation to estimate glomerular filtration rate.

  2009cited by this paper
• The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age.

  2006cited by this paper
• The burden of chronic kidney disease

  2006cited by this paper
• International comparison of the relationship of chronic kidney disease prevalence and ESRD risk.

  2006influential reference
• Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 Declaration.

  2005cited by this paper
• Estimation of Markov Chain Transition Probabilities and Rates from Fully and Partially Observed Data: Uncertainty Propagation, Evidence Synthesis, and Model Calibration

  2005influential reference
• Chronic renal diseases as a public health problem: epidemiology, social, and economic implications.

  2005cited by this paper
• The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease.

  2003cited by this paper
• The Statistical Analysis of Failure Time Data

  2003cited by this paper
• K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

  2002cited by this paper
• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

  1999cited by this paper
• Recursive Utility for Stochastic Trees

  1996cited by this paper
• Report based on the Centre Questionnaire, 1995

  1996cited by this paper
• Numerical transient analysis of markov models

  1988cited by this paper
• The Statistical Analysis of Failure Time Data

  1980cited by this paper
• The impact of heterogeneity in individual frailty on the dynamics of mortality

  1979cited by this paper
• Errors of Prediction for Markov Chain Models

  1975cited by this paper
• Some Results on Matrices Which Commute with Their Derivatives

  1967cited by this paper
• General theory of mortality and aging.

  1960cited by this paper

• Health disparities in transitions between kidney replacement therapy modalities and mortality in England: A multistate model using UK Renal Registry data.

  2026cites this paper
• Probability of progression and regression of chronic kidney disease in patients with type 2 diabetes mellitus.

  2025cites this paper
• Development of a Cohort Analytics Tool for Monitoring Progression Patterns in Cardiovascular Diseases: Advanced Stochastic Modeling Approach

  2024cites this paper
• Population-level detection of early loss of kidney function: 7-year follow-up of a young adult cohort at risk of Mesoamerican nephropathy

  2023cites this paper
• A continuous-time Markov chain model of fibrosis progression in NAFLD and NASH

  2023cites this paper
• Estimation of disease progression for ischemic heart disease using latent Markov with covariates

  2023cites this paper
• A Systematic Review of Kidney Transplantation Decision Modelling Studies

  2022cites this paper
• The Health Value of Kidney Exchange and Altruistic Donation.

  2021cites this paper
• A multi-state model for kidney disease progression

  2021cites this paper
• Profiling Delirium Progression in Elderly Patients via Continuous-Time Markov Multi-State Transition Models

  2021cites this paper
• Cohort state-transition models in R: From conceptualization to implementation

  2020cites this paper
• Using Markov Chain to Predict by the Natural Progression of Diabetic Nephropathy at Diabetes and Endocrinology Hospital

  2020cites this paper
• Cohort State-Transition Models in R: A Tutorial.

  2020cites this paper
• An Introductory Tutorial on Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example

  2020cites this paper
• A Multi-State Markov Model for the Progression of Chronic Kidney Disease Kronik

  2019cites this paper
• Projected impact of elbasvir/grazoprevir in patients with hepatitis C virus genotype 1 and chronic kidney disease in Vietnam.

  2019cites this paper
• The Landscape of Diabetic Kidney Disease in the United States

  2018cites this paper
• Exploring multi-state modelling in an epidemiological and health economics context

  2018influential citation
• Works Title The Landscape of Diabetic Kidney Disease in the United States Permalink

  2018cites this paper
• Cost-effectiveness analysis of elbasvir-grazoprevir regimen for treating hepatitis C virus genotype 1 infection in stage 4-5 chronic kidney disease patients in France

  2018cites this paper
• A three-state continuous time Markov chain model for HIV disease burden

  2018cites this paper
• A Reliability Model for the Progression of Chronic Heart Failure

  2018cites this paper
• Prediction of transfer among multiple states of blood pressure based on Markov model: an 18-year cohort study

  2018cites this paper
• Cost‐effectiveness of elbasvir/grazoprevir use in treatment‐naive and treatment‐experienced patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States

  2017cites this paper
• Study of Disease Progression and Relevant Risk Factors in Diabetic Foot Patients Using a Multistate Continuous-Time Markov Chain Model

  2016cites this paper
• Regression methods for investigating risk factors of chronic kidney disease outcomes: the state of the art

  2014cites this paper
• A Stochastic Model for the Progression of Chronic Kidney Disease

  2014cites this paper